Healthcare provider profile · identity verified

Evan Michael Hardesty, MD

Family Practice · STEAMBOAT SPRINGS, CO · NPI 1598257479

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	319	85
Levothyroxine Sodium	Levothyroxine Sodium	243	59
Tamsulosin Hcl	Tamsulosin Hcl	123	34
Trazodone Hcl	Trazodone Hcl	118	20
Lisinopril	Lisinopril	117	33
Rosuvastatin Calcium	Rosuvastatin Calcium	110	31
Sertraline Hcl	Sertraline Hcl	101	20
Metformin Hcl	Metformin Hcl	96	28
Losartan Potassium	Losartan Potassium	93	27
Amlodipine Besylate	Amlodipine Besylate	91	32
Furosemide	Furosemide	84	21
Zolpidem Tartrate	Zolpidem Tartrate	80	30
Gabapentin	Gabapentin	79	19
Pantoprazole Sodium	Pantoprazole Sodium	77	22
Potassium Chloride	Potassium Chloride	67	12
Eliquis	Apixaban	61	13
Alprazolam	Alprazolam	58	17
Alendronate Sodium	Alendronate Sodium	55	11
Metoprolol Succinate	Metoprolol Succinate	55	16
Omeprazole	Omeprazole	55	21
Allopurinol	Allopurinol	52	14
Lamotrigine	Lamotrigine	47	suppressed
Duloxetine Hcl	Duloxetine Hcl	46	suppressed
Myrbetriq	Mirabegron	44	suppressed
Levetiracetam	Levetiracetam	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	39	suppressed
Simvastatin	Simvastatin	39	12
Escitalopram Oxalate	Escitalopram Oxalate	37	11
Tramadol Hcl	Tramadol Hcl	36	12
Warfarin Sodium	Warfarin Sodium	36	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	33	13
Citalopram Hbr	Citalopram Hydrobromide	33	11
Meloxicam	Meloxicam	33	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Jardiance	Empagliflozin	26	suppressed
Ozempic	Semaglutide	26	suppressed
Finasteride	Finasteride	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Prednisone	Prednisone	25	20
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Xarelto	Rivaroxaban	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Glipizide	Glipizide	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	19	suppressed
Atenolol	Atenolol	18	suppressed
Azithromycin	Azithromycin	18	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Valsartan	Valsartan	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Carvedilol	Carvedilol	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Bupropion Xl	Bupropion Hcl	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Estradiol	Estradiol	12	suppressed
Topiramate	Topiramate	12	suppressed
Diazepam	Diazepam	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error